Sort
23,748 grants matching “melanoma”
Cytoplasmic mislocalization of p27Kip1 as a causative factor and prognostic marke
$232,361Peggy L Porter · Fred Hutchinson Cancer Research Center · P50 · FY2011 · CA
Multiscale modeling of leukocyte-tumor cell adhesion to endothelium in shear flow
$232,354Cheng Dong · Pennsylvania State University, The · R01 · FY2007 · CA
A statistical framework to systematically characterize cancer driver mutations in noncoding genomic regions
$232,291Eliezer M Van Allen · Dana-Farber Cancer Inst · R21 · FY2019 · CA
Preclinical Evaluation of VAX014 in Combination with Immune Checkpoint Inhibitors
$232,276Matthew Giacalone · Vaxiion Therapeutics, Inc. · R43 · FY2018 · CA
Tumor therapy with antiangiogenic beta-2-glycoprotein 1
$232,236Alan Jay Schroit · University Of Tx Md Anderson Can Ctr · R01 · FY2006 · CA
MELANOSOME PROTEIN SORTING, FOLDING &ANTIGEN PROCESSING
$232,210University Of Pennsylvania · R01 · FY2000 · EY
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
$232,187James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
CELL-SPECIFIC ISOTOPE LABELING TO TRACK INTERCELLULAR METABOLITE EXCHANGE IN CANCER
$232,181Gary J Patti · Washington University · R21 · FY2017 · CA
CELL-SPECIFIC ISOTOPE LABELING TO TRACK INTERCELLULAR METABOLITE EXCHANGE IN CANCER
$232,181Gary J Patti · Washington University · R21 · FY2016 · CA
Role of IDO in Malignancy
$232,151David H Munn · Augusta University · R01 · FY2006 · CA
CORE--TISSUE RESEARCH AND PATHOLGOGY SERVICES
$232,136Rajiv Dhir · University Of Pittsburgh At Pittsburgh · P30 · FY2007 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE
$232,131Frontier Sci &Technology Rsch Fdn, Inc · U10 · FY2003 · CA
Using gene expression profiles to elucidate mechanisms of melanoma progression
$232,066Ashani Weeraratna · National Institute On Aging · ZIA · FY2009 · AG
Development of an HTS assay for ySas2/hMOF histone acetyltransferase inhibitors
$232,042Ronen Marmorstein · Wistar Institute · R01 · FY2013 · GM
MOLECULAR MECHANISMS OF MELANOMA INVASIONS
$231,921State University New York Stony Brook · R01 · FY2000 · CA
ERK inhibitor resistance and ERK isoform-dependent growth in pancreatic cancer
$231,887Channing J Der · Univ Of North Carolina Chapel Hill · R21 · FY2014 · CA
Characterization of Cancer Transcriptomes using Next Generation Sequencing
$231,830Christopher A Maher · Washington University · R00 · FY2012 · CA
Advanced planar image reconstruction for targeted alpha therapy
$231,818Charles Ross Schmidtlein · Sloan-Kettering Inst Can Research · R21 · FY2023 · CA
An IL-12 family heterodimer that regulates IL-4 production by T cells
$231,750Nevil John Singh · University Of Maryland Baltimore · R21 · FY2021 · AI
Development of humanized TLR4 SNP mouse models
$231,750Adeline M Hajjar · University Of Washington · R21 · FY2014 · OD
Targeting defective spliceosomal pathway in myeloid malignancies
$231,699Chao-Yie Yang · University Of Tennessee Health Sci Ctr · R21 · FY2022 · CA
Flow Cytometry Core
$231,683W Martin Kast · University Of Southern California · P30 · FY2022 · CA
Improved Tumor Targeting of Salmonella VNP20009 via Ice-llama Antibody Guidance
$231,651Andrew Hayhurst · Texas Biomedical Research Institute · R21 · FY2014 · CA
Molecular Mechanisms of Prostate Cancer Chemoprevention by Apigenin
$231,636Sanjay Gupta · Case Western Reserve University · R01 · FY2014 · CA
Assessing the risk of UV-induced skin cancer via non-invasive epidermal sampling
$231,546Samir S Mitragotri · University Of California Santa Barbara · R21 · FY2015 · CA